Aerie Pharmaceuticals Q3 EPS $(0.27) Up From $(0.72) YoY, Sales $36.13M Up From $29.31M YoY
Aerie Pharmaceuticals Q3 EPS $(0.27) Up From $(0.72) YoY, Sales $36.13M Up From $29.31M YoY
Airie PharmPharmticals第三季度每股收益0.27美元，同比增長0.72美元，銷售額3613萬美元，同比增長2931萬美元
Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.27) per share. This is a 62.5 percent increase over losses of $(0.72) per share from the same period last year. The company reported $36.13 million in sales this quarter. This is a 23.25 percent increase over sales of $29.31 million the same period last year.
艾瑞製藥(納斯達克代碼：AAI)公佈季度虧損為每股0.27美元。這比去年同期每股虧損0.72美元增加了62.5%。該公司報告本季度銷售額為3613萬美元。這比去年同期2931萬美元的銷售額增長了23.25%。